Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities

M Kourti, M Aivaliotis, E Hatzipantelis - Diagnostics, 2023 - mdpi.com
Acute lymphoblastic leukemia (ALL) is the most common cancer in children and one of the
success stories in cancer therapeutics. Risk-directed therapy based on clinical, biologic and …

[HTML][HTML] Impact of the induction phase chemotherapy on cytokines and oxidative markers in peripheral and bone marrow plasma of children with acute lymphocytic …

GE Broto, PRB Silva, FC Trigo, VJ Victorino… - Current Research in …, 2021 - Elsevier
B-cell acute lymphocytic leukemia (B-ALL) is the main neoplasia affecting children
worldwide, in which cytotoxic chemotherapy remains the main treatment modality. In this …

Quantitative plasma proteomics to identify candidate biomarkers of relapse in pediatric/adolescent Hodgkin lymphoma

O Repetto, L Caggiari, M De Zorzi, C Elia… - International Journal of …, 2022 - mdpi.com
Classical pediatric Hodgkin Lymphoma (HL) is a rare malignancy. Therapeutic regimens for
its management may be optimized by establishing treatment response early on. The aim of …

[PDF][PDF] IV CONGRESSO NACIONAL DE CIÊNCIAS APLICADAS À SAÚDE 24 a 27 de agosto de 2021

ACAEA SUA - ANAIS DO IV CONGRESSO NACIONAL DE …, 2022 - e-revista.unioeste.br
As Infecções Sexualmente Transmissíveis (ISTs) são causadas por vírus, bactérias ou
outros microrganismos, sendo transmitidas, em sua maioria, através de contato sexual …